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Synthesis and Evaluation of Europium Complexes that Switch on
Luminescence in Lysosomes of Living Cells
Matthieu Starck,*[a] Jack D. Fradgley,[a] Robert Pal,[a] Jurriaan M. Zwier,[b] Laurent Lamarque,[b]
and David Parker*[a]
Abstract: A set of four luminescent EuIII complexes bearing
an extended aryl-alkynylpyridine chromophore has been
studied, showing very different pH-dependent behaviour in
their absorption and emission spectral response. For two
complexes with pKa values of 6.45 and 6.20 in protein-con-
taining solution, the emission lifetime increases very signifi-
cantly following protonation. By varying the gate time
during signal acquisition, the ‘switch-on’ intensity ratio could
be optimised, and enhancement factors of between 250 to
1330 were measured between pH 8 and 4. The best-behaved
probe showed no significant emission dependence on the
concentration of endogenous cations, reductants, and serum
albumin. It was examined in live-cell imaging studies to
monitor time-dependent lysosomal acidification, for which
the increase in observed image brightness due to acidifica-
tion was a factor of 50 in NIH-3T3 cells.
Introduction
We introduce a series of four EuIII complexes whose lumines-
cence emission is switched on by over two orders of magni-
tude during acidification, following excitation in the range 330
to 370 nm. Such complexes have utility in monitoring acidifica-
tion in living cells.
Receptor mediated endocytosis is a ubiquitous feature of
uptake into cells, following surface receptor membrane bind-
ing.[1] It leads to the internalisation of part of the cell surface re-
ceptors together with the bound molecular species. Thus, in a
typical clathrin-mediated cell uptake process[2] with a G-protein
coupled receptor (GPCR), binding of an agonist at the receptor
site may be followed by endosomal formation. The endosome
may either be degraded, or its contents recycled, releasing the
receptor to return to the plasma membrane. Much larger parti-
cles and species may be internalised by phagocytosis, after the
cell surface membrane is ruffled, leading to the budding-off of a
phagosome within the cell. For species of intermediate molecu-
lar weight (MW) and for certain other low MW molecules and a
large family of lanthanide coordination complexes, macropino-
cytosis may occur following invagination of the plasma mem-
brane after surface receptor binding.[3] The internalised macropi-
nosome is considered to be more leaky than endosomes or
vesicles, and discharges its contents more readily.
A common feature of the ageing process of endosomes and
phagosomes is that their pH tends to fall with time over the
cell cycle period, and endosomes may finally evolve into lyso-
somes. Thus, whilst cytosolic pH is around 7.2, endosomal pH
ranges from 6.5 to 5.5 and the lowest pH is to be found in
mature lysosomes and is typically around 4.5. The processes of
internalisation and endosomal uptake can therefore be fol-
lowed in time if the species being internalised (receptor or
substrate) is for instance labelled with a luminescent pH sensi-
tive dye whose emission intensity or lifetime varies with pH.
Ideally, the observed change should be as large as possible;[4]
in the limit, this is akin to the idea of a ‘light switch’, although
this term has sometimes been misused in the literature, and
occasionally rather modest emission intensity variations have
been unduly celebrated as ‘switch-on’ sensors. Ratiometric sys-
tems of course offer greater scope. For this work, we set our-
selves a target of a 100 % change in lifetime over the pH range
8–4, and a change in the long-lived emission intensity of two
orders of magnitude. Such desirable properties require careful
consideration of the mechanism of the process leading to
emission quenching at higher pH. In addition, the selection of
the pH range determines the pKa of the emissive species un-
dergoing protonation. Our initial work focused on examining
systems with pKa around 5.5–6.
The majority of work reported has involved an adaptation of
the molecular structure of common fluorophores, such as
rhodamine, BODIPY and various cyanine dyes, in order to tune
the pKa value and permit conjugation. Several of these exam-
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ples are now commercially available. Thus, the N,N’-fluoro-
ethylrhodamine derivative (RH-PEF) has been used to monitor
antibody internalisation,[5] the core structure has a pKa around
5.1 and the intensity increase is reported to be a factor of 58
between pH 7.4 and 5.0. Related studies have used fluorescent
cyanine dye labels and an assay was developed to track the in-
ternalisation of the HER-2 antibody,[6] while Grover et al.[7] ex-
amined GPCR labelling with cyanine dyes, giving modest inten-
sity enhancements of a factor of 5, between pH 5 and 8. Argu-
ably the most promising approach has used a modified
BODIPY core, and Nagano and colleagues[8] reported switching
factors of up to 300 using these systems. Here, the pKa is easily
tuned by variation of the aniline substituents R1 and R2: the
pKa increases from 3.8 to 6.0 in the sequence H<Me<Et, as
lone pair conjugation is increasingly disfavoured and the con-
jugate acid is less strongly stabilised by solvation. Such sys-
tems were used to examine breast cancer tissue samples and
permitted the internalisation of the antibody HER-2 receptor
complex to be followed by microscopy in mice, by labelling
the immunotherapeutic agent Herceptin (trastuzumab) with a
BODIPY dye.
These fluorescent systems offer neither significant lifetime
modulation, nor a ratiometric response and have the inherent
issues associated with autofluorescence. Others have therefore
sought to use luminescent lanthanide labels, and benefit from
the advantages (e.g., large Stokes shifts, long lifetimes), associat-
ed with time-resolved spectroscopy or microscopy methods.
Yuan and co-workers,[9] for example, has reported monitoring
the change in the red/green Eu to Tb emission intensity ratio in
a modified acyclic chelate based on a terpyridine ligand, leading
to a system with a ratiometric ratio variation of a factor of 7.
Papkovsky and colleagues[10] described a rather weakly emissive
EuIII DTPA complex based on a carbostyril sensitiser, in which
the lifetime and emission intensity at 614 nm changed by a
factor of 7 between pH 7.5 and 6.5 (pKa 6.5, lexc 370 nm), allow-
ing extracellular acidification to be monitored for a series of
high throughput assays. In another approach by Schferling and
co-workers,[10b] a EuIII chelate was coupled to carboxynaphtho-
fluorescein to create a ratiometric pH sensor, but this compound
is unlikely to work in a cellular environment.
Fewer time-resolved studies have examined pH change
inside cells directly, where either confocal microscopy directly
or spectral imaging can be employed, observing lifetime or
emission intensity modulation. Using kinetically stable macro-
cyclic ligand systems based on triazacyclononane, McMahon
et al.[11] devised EuIII complexes that permitted monitoring of
the pH of the endoplasmic reticulum in live cells, based on
emission lifetime variation; a 75 % change in the europium life-
time was observed over the pH range 6.5–7.5. Earlier, Smith
et al.[12] had described ratiometric methods that allow the real-
time monitoring of lysosomal pH, using confocal microscopy,
based on analysis of the Eu/Tb emission intensity ratio, that
varied from 1.3 at pH 4.6 to 2.9 at pH 6.5 (lexc 355 nm).
None of these lanthanide systems permits the conjugation
of the emissive probe to a targeting vector or protein. Such an
approach is straightforward to devise and simply requires a
suitable linkage site to be introduced into the ligand structure.
Accordingly, we set out to compare the pH response behav-
iour of a set of four luminescent EuIII complexes, in which the
site of protonation was either in partial conjugation with the
sensitising chromophore, [EuL3, 4] , or where a methylene spacer
insulates the amine site, [EuL1, 2] . In the latter case, it was rea-
soned that acidification would lead to suppression of photo-in-
duced electron transfer, from the nitrogen lone pair to the
chromophore excited state, enhancing the intensity of Eu
emission by analogy with a plethora of published exam-
ples.[4a, 13] Such a system was not expected to show any change
in the form of either emission or excitation spectra. With the
amine group in conjugation with one of the aromatic rings, it
was reasoned that the absorption spectrum would vary with
pH and that significant Eu lifetime and intensity change was
possible, as acidification would perturb the energy of the
ligand centred and internal charge transfer transitions that
exist in related examples of these ‘EuroTracker’ complexes.[14]
The nature of the substituents in the amine moiety was select-
ed bearing in mind the pKa values of simple anilines in aque-
ous media.
Thus, the series of Eu complexes [EuL1–4] was designed and
prepared and their photophysical behaviour examined, togeth-
er with preliminary studies of their localisation and time-de-
pendent behaviour in living cells, in the expectation that the
best examples could be taken forward as ‘core’ complexes,
from which analogues would be designed to allow conjuga-
tion, for future internalisation studies.
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The synthesis of the target complexes [EuL1] and [EuL3] was
undertaken as shown in Scheme 1 and Scheme 2. The structur-
ally related complexes, [EuL2] and [EuL4] , were made using sim-
ilar methods and details are given in the Supporting Informa-
tion.
Mono-alkylation of N-methylaniline with the substituted
benzylic bromide, 1, gave the tertiary amine 2, which was cou-
pled with trimethylsilylacetylene under palladium catalysis to
afford the alkyne 3, in 98 % yield. Following silyl deprotection
with fluoride in THF, the terminal alkyne 4 was coupled with
the 4-iodo-pyridine derivative 5,[15] in a copper(I) assisted reac-
tion to give the conjugated alkyne 6. Mesylation in THF afford-
ed the sulfonate ester, 7, which was used directly to alkylate
triazacyclononane in acetonitrile to yield the C3 symmetric
ligand precursor, 8. Following base hydrolysis, [EuL1] was pre-
pared by reaction of the ligand with EuCl3 at ambient pH, and
the neutral complex was purified by reversed-phase HPLC
(Scheme 1).
Scheme 2. Synthesis of [EuL3] .
Scheme 1. Synthesis of [EuL1] .
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In the case of [EuL3] , the electron-rich chromophore was in-
troduced in the final alkylation step to avoid undue exposure
to strong acid conditions during its preparation. The intermedi-
ate N,N-diethyl-substituted terminal alkyne, 15, was made from
3-amino-4-methoxy iodobenzene (Scheme 2) by a similar series
of standard alkylation, coupling and deprotection steps, prior
to a Sonagashira coupling reaction with the 4-bromopyridine
derivative, 9, that has been reported earlier.[16] The resultant
disubstituted alkyne 16 was mesylated using methanesulfonic
anhydride in THF in the presence of Hnig’s base, to avoid the
presence of chloride anion which can lead to unwanted dis-
placement of the mesylate group, under certain conditions. In
parallel, the diester, 20, was prepared from the mesylate 18[17]
and mono-BOC-triazacyclononane 19,[18] and the Boc group re-
moved by treatment with TFA. The resultant secondary amine
21, was alkylated with the mesylate of the conjugated chromo-
phore 17, and the triethyl ester 22, was hydrolysed in metha-
nolic aqueous base followed by complexation with europium
at ambient pH (Scheme 2). The desired charge neutral com-
plex, [EuL3] was purified by reversed-phase HPLC.
pH dependence of europium luminescence
The pH dependence of the absorption, emission and excitation
spectra for each complex was examined, together with meas-
urements of the europium emission lifetime (Table 1). Consid-
ering first the complex [EuL3] , as it contains only one site of
protonation at nitrogen. Protonation shifts the position of the
main p–p* transition from 340 nm to 320 nm, characterised by
the occurrence of two isosbestic points at 331 and 278 nm
(Figure 1). The Eu emission intensity increased markedly as the
pH was lowered from 10 to 4 (Figure 2) and was accompanied
by an increase in lifetime from 0.45 ms to 1.16 ms. Overall
emission quantum yields measured at pH 4 and pH 8 were
17 % and 0.5 % respectively. By fitting the variation of the Eu
emission intensity or its lifetime with pH, a pKa value was esti-
mated by nonlinear least squares regression analysis. A value
of 6.75(0.05) was found (Table 2, 295 K, 0.1 m NaCl). Identical
behaviour was found for both acidimetric and alkalimetric titra-
tions consistent with full reversibility.
Similar overall behaviour was found in the pH dependence
of [EuL4] , for which more complex absorption spectral changes
occurred (Supporting Information). In this case, the emission
quantum yield increased from 0.1 to 17 % from pH 8 to 4, and
the lifetime increased from 0.24 to 0.84 ms (Figure 3 and
Figure 4). The form of the Eu emission spectrum for [EuL3] and
[EuL4] was more or less unchanged, with only minor changes
observed in the hypersensitive DJ = 2 and 4 transitions, for ex-
ample, a switching in the relative intensity of the two main
bands in the region between 610 to 625 nm.
Table 1. Summary of photophysical properties for EuIII complexes (295 K, ccomplexes = 15 mm in 0.1 m NaCl).
Complex lexc [nm] e [M































[a] Values at pH 8; [b] values at pH 4; [c] values at the isosbestic point. Experimental errors on lifetime are 5 % and for quantum yields, 15 %.
Figure 1. Variation of the absorption spectrum of [EuL3] with pH revealing
the isosbestic points at 278 and 331 nm (295 K, ccomplex = 15 mm, 0.1 m NaCl).
Figure 2. Variation of the europium emission spectrum and lifetime with pH
for [EuL3] (lexc 331 nm, 295 K, ccomplex = 15 mm, 0.1 m NaCl) showing the fit
(line) to the experimental data. Similar plots were obtained for excitation at
337 or 355 nm.
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The variation of lifetime with pH allowed an apparent pKa to
be measured for [EuL4] (Table 2). In this case, three successive
protonation steps occur, but the data was fitted to a single
protonation event. The sites of protonation are separated by
at least 15 , and so can be considered to act independently.
The apparent pKa was 6.21(0.05) in this case, and it did not
change when 0.1 % bovine serum albumin solution was pres-
ent, suggesting little interaction with this common serum pro-
tein. However, in a cell lysate background, the pKa fell to 5.75.
The Eu complexes of L1 and L2 are sparingly soluble in water,
and slowly came out of solution on standing at higher pH,
with evidence for pH induced aggregation (Supporting Infor-
mation Figures S3 and S5). However, each complex dissolved
readily in methanol, in which they were strongly emissive, with
overall photoluminescence quantum yields of 24 and 48 % re-
spectively for the protonated species. In water, quantum yields
were lower (4 and 12 % at pH 7; 12 and 19 % at pH 4), as
found for related EuroTrackerTM probes that also possess a
strong internal charge transfer transition.[14a, b, 19] The europium
emission lifetime at pH 7 was 0.70 ms for each complex, and
decreased by only 10 and 14 % respectively, between pH 8 and
4. At the same time, the Eu emission intensity showed an in-
crease in intensity: for [EuL1] , the intensity increase was 330 %
from pH 8 to 4, and for [EuL2] the corresponding change was
55 %. Such behaviour accords with predominant suppression
of photoinduced electron transfer of an intermediate ligand
based excited state, following complex protonation. Given the
inferior solubility and pH dependent switching properties of
[EuL1, 2] , further studies focused on the properties of the com-
plexes of L3 and L4, and [EuL4] was selected for particular atten-
tion by virtue of its more favourable pKa value, with a view to
its use in cellulo.
The large increase of the Eu emission lifetime that occurs on
protonation with [EuL4] allows the apparent switching ratio be-
tween the ‘on’ and ‘off’ states to be varied, by changing the
time delay in signal acquisition. Two cases were investigated in
which either a fixed time delay was introduced, or a different
time window for spectral acquisition was selected (Table 3 and
Figure 5). The emission intensities were measured in buffered
solution at pH 4 and pH 8, and the ratios of the overall europi-
um emission intensities were measured in each case. By chang-
ing the delay time from 0.06 ms to 1 ms, the ‘switch-on’ factor
increased from 250 to 650, with an apparent pKa of 5.7(0.1)
under these different sets of experimental conditions. By
choosing different time windows, a slightly greater increase in
this factor was found, with the maximum ratio found for the
time window 1.5 to 2.5 ms, notwithstanding the decrease in
Table 2. Summary of pKa values (0.05) determined for [EuL1–4]
(ccomplexes = 15 mm) in the stated media.
Complex Conditions pKa
[EuL1] 0.1 m NaCl n.d.[a]
[EuL2] 0.1 m NaCl 6.48
[EuL3] 0.1 m NaCl
0.1 m NaCl, 0.1 mm BSA
6.75
6.45
[EuL4] 0.1 m NaCl





[a] Not determined; see Supporting Information.
Figure 3. Absorption, excitation and metal-based emission spectra for [EuL4]
(lexc 331 nm, 295 K, ccomplex = 15 mm, 0.1 m NaCl), showing the highest-energy
transitions from the 5D0 excited state.
Figure 4. Variation of the europium emission spectrum and lifetime with pH
for [EuL4] (lexc 331 nm, 295 K, ccomplex = 15 mm, 0.1 m NaCl) showing the fit
(red) to the data points. Similar plots were obtained for excitation at 337
and 355 nm, or using emission intensity variations.
Table 3. Ratios of emission intensities (‘switch-on’ factors) for the stated
single gate delay times or differing time gate periods, showing the effect
on the apparent pKa values.
[a]
t [ms] pH 4/pH 8 app. pKa








[a] 295 K, c = 15 mm, 0.1 m NaCl; buffers, NH4OAc (0.1 m, pH 4), NH4HCO3
(0.1 m, pH 8).
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overall signal intensity that occurs using an acquisition period
that is rather longer than the emission lifetime. Such behaviour
augurs well for such conditions to be employed in either a
time-gated assay, or in future time-resolved microscopy stud-
ies.
Cell imaging studies and control experiments
Cell uptake and co-localisation studies were undertaken for
[EuL4] in living mouse skin fibroblasts (NIH-3T3) and human
breast cancer cells (MCF-7), following methods previously re-
ported.[3b, 14c, 19] The extent of complex uptake was monitored
by assessing image brightness as a function of time. In parallel,
complex concentrations at fixed time points were measured
by analysing the Eu concentration in these cell samples, using
ICP-mass spectrometry (Figure S11). Co-staining experiments
using Lysotracker Green (Figure 6), verified that the complex
was localised in the lysosomes, with higher correlation coeffi-
cients as probe brightness increased, within a given cell cycle.
The microscopy study revealed a time dependent increase
in brightness that maximised at around 16 to 18 hours. Such
behaviour coincides with the time period of mitosis for NIH-
3T3 cells ; during unaltered proliferation, they divide every 16
hours. In a separate study, cell toxicity was assessed using live/
dead assay image cytometry (Supporting Information), and no
evidence (5 %) for perturbation of natural cell homeostatic
function and proliferation was found over a period of 24
hours, for concentrations of up to 100 mm.
After cell division, the daughter cells appeared less bright, in
line with the increase in cell volume. Each daughter cell pos-
sesses about 50 % of the internalised complex of the parent
cell, as they begin their independent life cycle. The concentra-
tion of complex found inside the cell then increases again, as
the daughter cells mature and embark on homeostatic uptake
of nutrients and [EuL4] present in the cell growth medium.
However, this process has a time lag, resulting in the observed
time vs. brightness profile (Figure 7). Similar overall behaviour
was found in a separate study where the concentration of the
Eu complex was 10 times lower.
In a control experiment with a structurally analogous com-
plex, D-[EuL5] , that shows no pH dependent behaviour and a
predominant lysosomal staining pattern, very different behav-
iour was observed.[20] In this case (Figure 8), under the same in-
Figure 5. Emission intensity of [EuL4] (lem 613 nm) as a function of pH with
different time periods of acquisition (blue = 60–460 ms, red = 1000–2000 ms,
green = 1500–2500 ms). Data are normalised to a 60–460 ms time window at
pH 4. Measurements were taken in aqueous solutions of NH4OAc (pH 4 and
5), MES (pH 5.5, 6, and 6.5), HEPES (pH 7) and NH4HCO3 (pH 8) buffers
(ccomplex = 15 mm, 0.1 m buffer in 0.1 m NaCl).
Figure 6. Live cell images (NIH-3T3) with [EuL4] after 16 h. Left : [EuL4] (ccomplex = 30 mm, lexc = 355 nm, lem = 600–720 nm); Centre: Lysotracker Green
(lexc = 488 nm, lem = 500–530 nm); Right: overlay shows co-localisation (P>0.95). Note the observation of normal cell division at 16 h.
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cubation conditions in NIH-3T3 cells, the mean image bright-
ness reached a plateau after 4 h, and remained constant there-
after, with a minor inflection around 16–18 h. Such a kinetic in-
tensity profile is characteristic of the EuroTracker series of Eu
complexes, studied in depth for several living cells.[14, 19]
A series of control experiments in vitro was also undertaken,
in order to verify that the changes in image brightness in the
cell imaging work were not due to any excited state quench-
ing by common endogenous species whose concentration
could hypothetically change in the same time period in the
given organelles. Accordingly, the Eu lifetime and observed
emission intensity were measured for [EuL4] in the presence of
increasing concentrations of different species that are likely to
be present inside the cell compartment. No significant changes
in lifetime or intensity were observed following addition of up
to 5 equivalents (corresponding to a limiting 150 micromolar
concentration) of Mg, Ca and Zn ions. Similarly, no changes
were found, within experimental error, for addition of the en-
dogenous reductants ascorbate, urate and glutathione that
can potentially quench the probe excited state by electron
transfer. Finally, no major variations (10 %) were found for
added bovine serum albumin that is present in the cell
incubation medium. The insensitivity to change compared
with the direct dependence on local pH is highlighted below
(Figure 9).
The time dependent increase in brightness in the cell experi-
ments with [EuL4] in theory can be attributed both to changes
in the extent of uptake (likely proceeding via macropinocytosis
as found in related studies),[3b, 20] and the pH drop in the
ageing endosomes as they transform into lysosomes. Control
experiments measuring the intracellular concentration of the
Eu-complex directly using ICP-MS were therefore undertaken
at 2, 4, 8, 12, 16 and 24 hours (Figure S11). These studies
showed a significantly less steep increase, with the intracellular
Eu concentration doubling between 2 and 16 hours, while the
observed image brightness increased by a factor of 50.
Such behaviour is consistent with the idea that the bright-
ness enhancement is not simply due to the slow increase in
the total amount of complex internalised, but directly relates
to the effect of diminishing pH in the ageing endosomes/lyso-
somes, with the associated large increase of Eu emission inten-
sity as the percentage of the more emissive protonated com-
plex increases. This hypothesis is also consistent with the ob-
served time dependent increase in Pearson’s co-localisation co-
efficient (P), in the parallel microscopy study using LysoTracker
Green (Figure 7).
After a separate 16 hours incubation in NIH-3T3 cells with
[EuL4] (30 mm), nigericin (200 nm) was added. This is an agent
that has been shown to increase lysosomal pH quickly, from
~4.5 to 6.5. After 5 minutes, confocal microscopy studies
Figure 7. Brightness profile of [EuL4] as a function of time for incubation concentrations of 30 mm (black) and 3 mm (red) in living NIH-3T3 cells ; images shown
are for 30 mm. Scale bar: 20 mm. The cells were monitored for 72 h, when the cells were proliferating normally.
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showed that the Eu complex appeared to be considerably less
bright overall, consistent with the increased size of the treated
cell’s lysosomes and the decreased probe brightness at the
higher pH value (Figure S9). In an additional control experi-
ment, the internalised complex concentration of both treated
and untreated cells, for a given time incubation time point,
was found to be identical within experimental error, using ICP-
MS. Parallel results were observed, in terms of localisation be-
haviour and time-dependent brightness change, using the
MCF-7 breast cancer cell line. An MTT assay assessment was
also undertaken, with no evidence found for cellular toxicity
with [EuL4] monitoring mitochondrial redox status for 24 h
over the concentration range 10 to 100 mm (Figure S10).
It should be noted in a word of caution, that the limitations
of the experimental approach where additions of agents that
greatly perturb cellular permeability have been noted.[3b, 21] The
use of the fluorescent LysoSensor probe for example, has been
advocated for lysosomal pH assessment, but it is only useful
for very short perturbational periods, as it induces changes
Figure 8. Brightness profile of D-[EuL5] as a function of time in live NIH-3T3 cells ; images shown are for a 30 mm incubation. Scale bar : 20 mm. The cells were
monitored for 48 h, and were proliferating normally.
Figure 9. Total change in emission lifetime (blue) and emission intensity
(red) following addition of 5 equivalents of analyte to [EuL4] (ccomplex = 30 mm,
0.1 m NaCl, 0.1 m NH4HCO3 buffer, pH 5) relative to the pH change observed
from 8 to 4 (normalised to unity). Lifetime and intensity data are given in
Figure S8.
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itself on the local pH and is only applicable to imaging studies
carried out over a few minutes,[21a] or in dead (fixed) cells. Stud-
ies with fixed cells have very clear limitations with respect to
the monitoring of living processes. The observations reported
here, of the continuous monitoring of cellular acidification
over a period of up to 24 h in live cells, have no obvious prece-
dent for a pH sensitive phosphorescent probe that has no ap-
parent effect on cellular homeostasis.
Conclusions
Four new luminescent EuIII complexes have been prepared and
evaluated in a series of comparative studies, assessing their ab-
sorption and emission spectral behaviour as a function of pH.
The Eu complexes of L1 and L2, where the site of protonation is
separated from the main chromophore by a methylene group,
showed no significant variation in absorption spectral form
and exhibited the smallest changes in emission intensity and
lifetime. In contrast, the protonation of complexes of L3 and L4,
where the amine group is conjugated into the phenyl ring,
caused a hypsochromic shift in the main absorption band and
an increase in the Eu lifetime of 120 and 240 % respectively. By
varying the delay time or the time period for acquisition of Eu
emission spectral intensity data, intensity ratios of between
250 and 1300 were measured for [EuL4] , comparing pH 4 and
pH 8 samples. The Eu emission lifetime and intensity was more
or less invariant to the concentration of Ca, Mg and Zn ions, to
the natural electron-rich reductants ascorbate, urate and gluta-
thione and to the protein BSA, each of which may potentially
perturb the behaviour of a probe luminophore in the living
cell. Such large pH induced ‘switching on’ factors are well
suited to assays where acidification needs to be monitored, as
occurs during the maturation of endosomes or in the ageing
of lysosomes, following uptake of a labelled protein or anti-
body.
The complex [EuL4] was examined in two different cell lines
and was found to localise mainly in the cellular lysosomes,
without compromising cellular viability or proliferation. Using
laser scanning confocal microscopy, exciting the complex at
355 nm, an increase in probe brightness was observed in the
living cells as a function of time, over the period 2 h to 16 h.
The observed brightness was 25 times greater than the
change associated with the independently measured increase
in probe uptake. In control experiments with a related com-
plex, [EuL5] , that exhibits no dependence of emission on pH,
very different behaviour was observed and no significant
changes in image brightness were observed beyond the de-
pendence on the extent of uptake. Taken together, such be-
haviour is consistent with the monitoring of acidification of
the cell’s lysosomes as they age using this pH sensitive probe.
Given that the cells were healthy, cell division occurred after
16–18 h and after a dip in probe brightness, the daughter cells
continued to take up the complex and their lysosomes were
subsequently observed to reach maturation.
Thus, the complex [EuL4] is well suited as the basis of probe
design for new systems that can be linked to targeting vectors
and antibodies to monitor receptor internalisation. Such new
derivatives can be used to tag proteins selectively, to monitor
the time-dependence of uptake into more acidic organelles
and their recycling, in order to enhance the performance of
current state-of-the-art, time-resolved internalisation assays.[22]
Such studies have been undertaken and the promising behav-
iour of these pH sensitive probes will be reported in due
course.
Experimental Section
Details of general experimental methods, instrumentation, cell mi-
croscopy and the photophysical techniques used are given in the
Supporting Information. Methyl 6-(hydroxymethyl)-4-iodopicolinate
5,[15] 4-bromo-2-hydroxymethyl-6-methylphosphinate pyridine 9,[16]
(6-(ethoxy(methyl)phosphoryl)pyridin-2-yl)methyl methanesulfo-
nate) 18,[17] and tert-butyl 1,4,7-triazacyclonane-1-carboxylate 19,[18]
were prepared using reported procedures. Details of the syntheses
of [EuL2] and [EuL4] are given in the Supporting Information, to-
gether with spectral data for ligand intermediates, additional spec-
tral information for each complex, and LC–MS data for the Eu com-
plexes.
4-Bromo-2-(bromomethyl)-1-methoxybenzene, 1: To a solution of
(5-bromo-2-methoxy-benzyl alcohol (623 mg, 2.87 mmol) dissolved
in anhydrous DMF (15 mL) under argon was added PBr5 (1.85 g,
4.32 mmol). The solution was stirred at 50 8C for 18 h under argon.
Solvent was removed under reduced pressure to yield an orange
oil. The residue was dissolved in CH2Cl2 (20 mL) and water (20 mL)
was added. The aqueous layer was extracted with CH2Cl2 (3 
10 mL), and the combined organic layers were dried over Na2SO4,
filtered and concentrated to dryness to yield a light-yellow oil that
was purified by column chromatography (SiO2, CH2Cl2 100 %) to
yield a white solid (740 mg, 92 %); Rf = 0.76 (SiO2, 100 % CH2Cl2);
mp: 114–116 8C; 1H NMR (298 K, 400 MHz, CDCl3): dH = 7.47 (1 H, d,
J = 2.5 Hz), 7.40 (1 H, dd, J = 9.0 Hz, J = 2.5 Hz), 6.78 (1 H, d, J =
9.0 Hz), 4.48 (2 H, s), 3.88 (3 H, s) ; 13C NMR (298 K, 100 MHz, CDCl3):
dC = 156.6, 133.6, 132.8, 128.3, 112.8, 112.7, 56.0, 27.7; (GC–MS) tR =
4.46 min, m/z 279.950 [M+] , 199.000 [MBr]+ ·, elemental analysis
calculated for C8H8Br2O (%): C = 34.32, H = 2.88; found: C = 34.09,
H = 2.88.
N-(5-Bromo-2-methoxybenzyl)-N-methylaniline, 2 : Compound 1
(78 mg, 0.28 mmol) was dissolved in dry CH3CN (2 mL). N-Methyl
aniline (31 mL, 0.28 mmol) and K2CO3 (78 mg, 0.56 mmol) were
added under argon. The reaction was stirred at 50 8C for 24 h
under argon and progress was monitored by LC–MS. The excess in-
organic salts were removed by filtration and the filtrate was evapo-
rated to dryness. The residue was dissolved in a CH2Cl2/water solu-
tion (20 mL, 1:1) and the aqueous layer was extracted with CH2Cl2
(3  10 mL). The combined organic layers were dried over Na2SO4,
filtered and concentrated to dryness affording a colourless oil
(80 mg, 94 %). NMR analysis and LC–MS shown that compound 2
was sufficiently pure to be used in the next step without further
purification; Rf = 0.90 (SiO2, 100 % CH2Cl2) ;
1H NMR (298 K, 400 MHz,
CDCl3): dH = 7.42 (1 H, d, J = 2.5 Hz), 7.36–7.28 (3 H, m), 6.90–6.76
(4 H, m), 4.57 (2 H, s), 3.92 (3 H, s), 3.13 (3 H, s) ; 13C NMR (298 K,
100 MHz, CDCl3): dC = 156.2, 149.6, 130.4, 129.8, 129.3, 129.2, 116.6,
113.1, 112.1, 111.8, 55.5, 52.0, 38.7; (HRMS +) m/z 306.0490 [M+H]+
(C15H17NOBr requires 306.0494).
N-(2-Methoxy-5-((trimethylsilyl)ethynyl)benzyl)-N-methylaniline,
3 : Compound 2 (105 mg, 0.34 mmol) was dissolved in dry THF
(3 mL) followed by addition of Pd(PPh3)2Cl2 (35 mg, 0.05 mmol),
TMS-acetylene (250 mL, 1.7 mmol) and pyrrolidine (168 mL, 2 mmol)
under argon. The reaction was stirred at 50 8C for 48 h under
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argon. After LC–MS analysis indicated reaction completion, solvent
was removed under reduced pressure and the residual dark-brown
oil was dissolved in CH2Cl2/water (40 mL, 1:1). The aqueous layer
was extracted with CH2Cl2 (3  10 mL) and the combined organic
layers were dried over Na2SO4, filtered and concentrated to dryness
to give a crude dark-brown oil that was purified by column chro-
matography (SiO2, hexane to EtOAc 2 % in hexane) to afford a
yellow oil (108 mg, 98 %); Rf = 0.32 (SiO2, 2 % EtOAc in hexane);
1H NMR (298 K, 400 MHz, CDCl3): dH = 7.40 (1 H, dd, J = 8.0 Hz, J =
2.0 Hz), 7.28–7.21 (3 H, m), 6.83 (1 H, d, J = 8.0 Hz), 6.78–6.68 (3 H,
m), 4.46 (2 H, s), 3.88 (3 H, s), 3.05 (3 H, s), 0.23 (9 H, s) ; 13C NMR
(298 K, 100 MHz, CDCl3): dC = 157.4, 149.8, 132.3, 130.6, 129.1,
127.0, 116.3, 115.1, 112.1, 109.8, 105.5, 92.3, 55.4, 52.2, 38.5, 0.1;
(HRMS +) m/z 324.1779 [M+H]+ (C20H26NOSi requires 324.1784).
N-(5-Ethynyl-2-methoxybenzyl)-N-methylaniline, 4 : Compound 3
(335 mg, 1.04 mmol) was dissolved in dry THF (4.5 mL) before
NEt3·3 HF (4.5 mL, 24 mmol) was added. The solution was stirred at
30 8C for 24 h under argon, when solvent was removed under re-
duced pressure and the residual oil was dissolved in CH2Cl2/water
(40 mL, 1:1). The aqueous layer was extracted with CH2Cl2 (3 
20 mL) and the combined organic layers were dried over Na2SO4,
filtered and concentrated to dryness to yield a light-orange oil. The
residual oil was purified by column chromatography (SiO2, hexane
to 2 % EtOAc in hexane) to yield a light-yellow oil (255 mg, 98 %);
Rf = 0.25 (SiO2, 2 % EtOAc in hexane);
1H NMR (298 K, 400 MHz,
CDCl3): dH = 7.42 (1 H, dd, J = 8.0 Hz, J = 2.0 Hz), 7.28–7.21 (3 H, m),
6.85 (1 H, d, J = 8.0 Hz), 6.78–6.68 (3 H, m), 4.49 (2 H, s), 3.90 (3 H, s),
3.07 (3 H, s), 2.96 (1 H, s) ; 13C NMR (298 K, 100 MHz, CDCl3): dC =
157.6, 149.6, 132.3, 130.9, 129.2, 127.2, 116.4, 114.0, 112.1, 109.9,
84.0, 75.7, 55.4, 52.0, 38.6; (HRMS +) m/z 252.1383 [M+H]+
(C17H18NO requires 252.1388).
Methyl-6-(hydroxymethyl)-4-((4-methoxy-3-((methyl(phenyl)ami-
no)methyl)phenyl)ethynyl)picolinate, 6 : Methyl 6-(hydroxymeth-
yl)-4-iodopicolinate 5 (64 mg, 0.22 mmol) was dissolved in dry THF
(1 mL) and NEt3 (150 mL, 1.1 mmol) was added. The solution was
degassed three times (freeze–thaw cycles). Compound 4 (60 mg,
0.24 mmol) and Pd(PPh3)2Cl2 (21 mg, 0.03 mmol) were added and
the solution was degassed once more. CuI (11.5 mg, 0.06 mmol)
was added and the reaction was stirred at 60 8C for 24 h under
argon. After this time, solvent was removed under reduced pres-
sure and the residual oil was purified by column chromatography
(SiO2, CH2Cl2 to 2 % MeOH in CH2Cl2) to yield a red oil (58 mg,
64 %); Rf = 0.30 (SiO2, 2 % MeOH in CH2Cl2) ;
1H NMR (298 K,
400 MHz, CDCl3): dH = 8.07 (1 H, s), 7.60 (1 H, s), 7.49 (1 H, dd, J =
8.0 Hz, J = 2.0 Hz), 7.33 (1 H, d, J = 2 Hz), 7.28–7.23 (2 H, m), 6.92
(1 H, d, J = 8.0 Hz), 6.78–6.70 (3 H, m), 4.86 (2 H, s), 4.51 (2 H, s), 4.00
(3 H, s), 3.93 (3 H, s), 3.65 (1 H, br. s), 3.10 (3 H, s) ; 13C NMR (298 K,
100 MHz, CDCl3): dC = 165.3, 160.6, 158.3, 149.6, 146.9, 133.9, 132.3,
130.6, 129.2, 128.7, 128.5, 127.6, 116.4, 113.6, 112.0, 110.2, 96.3,
85.1, 64.5, 55.5, 53.0, 52.0, 38.7; (HRMS +) m/z 417.1807 [M+H]+
(C25H25N2O4 requires 417.1814).
Methyl-4-((4-methoxy-3-((methyl(phenyl)amino)methyl)phenyl)-
ethynyl)-6-(((methylsulfonyl)oxy)methyl)picolinate, 7: The alcohol
6 (30 mg, 72 mmol) was dissolved in anhydrous THF (1 mL) under
argon. Mesyl chloride (8 mL, 108 mmol) and NEt3 (34 mL, 252 mmol)
were added under argon and the reaction was stirred at ambient
temperature for 2 h. After this time, solvent was removed under re-
duced pressure and the residue was dissolved in CH2Cl2/water (1:1,
20 mL). The aqueous layer was extracted with CH2Cl2 (3  10 mL).
The combined organic layers were dried over Na2SO4, filtered and
concentrated to dryness to yield a pale-pink oil (35.7 mg, quant)
that was sufficiently pure to be used for the next step without fur-
ther purification; 1H NMR (298 K, 400 MHz, CDCl3): dH = 8.15 (1 H, d,
J = 2.0 Hz), 7.70 (1 H, d, J = 2.0 Hz), 7.51 (1 H, dd, J = 8.0 Hz, J =
2 Hz), 7.35 (1 H, d, J = 2.0 Hz), 7.26 (2 H, td, J = 7.0, Hz, J2 = 2 Hz),
6.93 (1 H, d, J = 8.0 Hz), 6.79–6.69 (3 H, m), 5.41 (2 H, s), 4.51 (2 H, s),
4.02 (3 H, s), 3.94 (3 H, s), 3.17 (3 H, s), 3.11 (3 H, s). UPLC (ES+ MS,
CH3CN/H2O, 0.1 % formic acid) tR = 3.40 min, m/z 496.517 (69 %,
[M+H]+), 989.170 (100 %, [2 m]+).
Trimethyl-6,6’,6’’-((1,4,7-triazacyclononane-1,4,7-triyl)tris(methy-
lene))tris(4-((4-methoxy-3-((methyl(phenyl)amino)methyl)phen-
yl)ethynyl)picolinate), 8 : 1,4,7-Triazacyclononane trihydrochloride
(5.7 mg, 24 mmol) and the mesylate 7 (35.7 mg, 72 mmol) were dis-
solved in anhydrous CH3CN (2 mL) and K2CO3 (20.0 mg, 144 mmol)
was added. The mixture was stirred at 60 8C for 24 h under argon.
The excess potassium salts were removed by filtration and the fil-
trate was concentrated to dryness to yield an orange oil (27 mg,
85 %). This compound was used directly in the next step without
further purification; 1H NMR (298 K, 400 MHz, CDCl3): dH = 8.01 (3 H,
d, J = 2.0 Hz), 7.82 (3 H, br. s), 7.45 (3 H, dd, J1 = 8.0 Hz, J = 2 Hz),
7.31 (1 H, d, J = 2.0 Hz), 7.21 (6 H, td, J = 7.0, Hz, J = 2 Hz), 6.89 (3 H,
d, J = 8.0 Hz), 6.71–6.68 (9 H, m), 4.48 (6 H, s), 3.96 (6 H, s), 3.92
(18 H, s), 3.05 (9 H, s), 2.92 (12 H, br. s) ; 13C NMR (298 K, 100 MHz,
CDCl3): dC = 165.5, 158.1, 149.6, 147.3, 132.3, 132.0, 130.6, 129.1,
128.6, 128.5, 127.9, 127.5, 116.4, 113.8, 112.0, 110.1, 95.7, 85.3, 64.1,
55.5, 52.9, 52.1, 38.6, 31.9; UPLC (CH3CN/H2O, 0.1 % formic acid)
tR = 3.59 min; (HRMS +) m/z 1324.622 [M+H]
+ (C81H82N9O9 requires
1324.624).
[EuL1]: Compound 8 (27 mg, 20.4 mmol) was dissolved in a solution
of CH3OH (1 mL), and a solution of aqueous sodium hydroxide
(1 mL, 0.1 m) was added to reach pH 12. The solution was heated
at 60 8C overnight, before it was adjusted to pH 7 by addition of a
1 m HCl solution. EuCl3·6 H2O (8.5 mg, 23 mmol) was added and the
solution was stirred at 60 8C for 12 h. After this time, the solution
was removed under reduced pressure to yield the crude EuIII com-
plex as a yellow solid (bright red under long-wave UV light). The
complex was purified by reversed-phase HPLC (CH3CN/25 mm am-
monium bicarbonate buffer) to give a yellow powder (4 mg, 14 %)
after freeze drying; UPLC (CH3CN/H2O, 0.1 % formic acid) tR =
3.65 min; (HRMS +) m/z 1430.471 [M+H]+ (C78H73N9O9
151Eu requires
1430.473); tH2O = 0.70 ms (pH 7); tD2O = 0.79 ms; tMeOH = 0.85 ms;
q = 0; lmax = 340 nm; e340 nm = 34 200 m
1·cm1 (pH 7); FH2O = 4.0 %
(pH 7), FMeOH = 24 %.
N,N-Diethyl-5-iodo-2-methoxyaniline, 13 : 2-Iodo-2-methoxyani-
line (2.83 g, 8.03 mmol) was dissolved in anhydrous CH3CN (15 mL)
and iodoethane (7 mL, 87 mmol) and K2CO3 (6.3 g, 45.6 mmol)
were added under argon. The reaction mixture was heated at 60 8C
for 48 h. After total conversion of the starting material, the excess
of K2CO3 was removed by filtration and the filtrate was concentrat-
ed to dryness. The residual oil was dissolved in CH2Cl2/water
(40 mL, 1:1), and the aqueous layer was extracted with CH2Cl2 (3 
20 mL). The combined organic layers were dried over Na2SO4, fil-
tered and concentrated to dryness to give a light-yellow oil that
was purified by column chromatography (SiO2, 100 % CH2Cl2 to 2 %
MeOH in CH2Cl2) to afford a colourless oil (2.16 g, 62 %); Rf = 0.18
(SiO2, 100 % CH2Cl2).
1H NMR (298 K, 400 MHz, CDCl3): dH = 7.26 (1 H,
dd, J = 8.0 Hz, J = 2.0 Hz), 7.17 (1 H, d, J = 2.0 Hz), 6.60 (1 H, d, J =
8.0 Hz), 3.83 (3 H, s), 3.14 (4 H, q, J = 7.0 Hz), 1.04 (6 H, t, J = 7.0 Hz);
13C NMR (298 K, 100 MHz, CDCl3): dC = 153.6, 141.1, 131.1, 130.1,
113.5, 83.1, 55.5, 46.0, 12.0; (HRMS +) m/z 306.0353 [M+H]+
(C11H17NOI requires 306.0355).
N,N-Diethyl-2-methoxy-5-((trimethylsilyl)ethynyl)aniline, 14 :
Compound 13 (1.58 g, 5.18 mmol) was dissolved in dry THF
(10 mL) before addition of Pd(PPh3)2Cl2 (364 mg, 0.5 mmol), TMS-
acetylene (3.80 mL, 25.9 mmol) and pyrrolidine (2.20 mL,
25.9 mmol). The reaction was stirred at 50 8C for 24 h under argon.
After LC–MS analysis indicated reaction completion, solvent was re-
moved and the residual dark-brown oil was dissolved in CH2Cl2/
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water (40 mL, 1:1). The aqueous layer was extracted with CH2Cl2
(3  10 mL). The combined organic layers were dried over Na2SO4,
filtered and concentrated to dryness to give a crude dark-brown
oil. This was purified by column chromatography (SiO2, CH2Cl2
100 %) to give a dark-brown oil (1.41 g, quant.) ; Rf = 0.65 (SiO2, 2 %
MeOH in CH2Cl2) ;
1H NMR (700 MHz, CDCl3): dH = 7.12 (1 H, d, J =
8.0 Hz), 7.03 (1 H, s), 6.75 (1 H, d, J = 8.0 Hz), 3.85 (3 H, s), 3.14 (4 H,
q, J = 7.0 Hz), 1.01 (6 H, t, J = 7.0 Hz), 0.24 (9 H, s) ; 13C NMR
(176 MHz, CDCl3): dC = 154.5, 139.1, 127.2, 125.3, 115.1, 111.2, 105.9,
91.9, 55.6, 46.1, 12.1, 0.3. ; (HRMS +) m/z 276.1770 [M+H]+
(C16H26NOSi requires 276.1784).
N,N-Diethyl-5-ethynyl-2-methoxyaniline, 15 : Compound 14
(1.41 g, 5.13 mmol) was dissolved in dry THF (10 mL), then
NEt3·3 HF (5.0 mL, 26.7 mmol) was added. The reaction was stirred
at 30 8C for 24 h under argon. After this time, solvent was removed
and the residual oil was dissolved in CH2Cl2/water (40 mL, 1:1). The
aqueous layer was extracted with CH2Cl2 (3  20 mL) and the com-
bined organic layers were dried over Na2SO4, filtered and concen-
trated to dryness to yield a light-orange oil that was purified by
column chromatography (SiO2, hexane to 2 % EtOAc in hexane) to
afford a light-brown oil (0.73 g, 75 %); Rf = 0.65 (SiO2, 2 % MeOH in
CH2Cl2) ;
1H NMR (700 MHz, CDCl3): dH = 7.14 (1 H, dd, J = 8.0 Hz, J =
2.0 Hz), 7.06 (1 H, d, J = 2.0 Hz), 6.78 (1 H, d, J = 8.0 Hz), 3.86 (3 H, s),
3.15 (4 H, q, J = 7.0 Hz), 2.98 (1 H, s), 1.02 (6 H, t, J = 7.0 Hz); 13C NMR
(176 MHz, CDCl3): dC = 154.6, 139.2, 127.1, 125.3, 113.9, 111.3, 84.4,
75.3, 55.7, 46.1, 12.1; (HRMS +) m/z 204.1401 [M+H]+ (C13H18NO re-
quires 204.1388).
Ethyl-(4-((3-(diethylamino)-4-methoxyphenyl)ethynyl)-6-(hydroxy
methyl)pyridin-2-yl)(methyl)phosphinate, 16 : To a solution of
compound 15 (55 mg, 0.27 mmol) and compound 9 (73 mg,
0.25 mmol) in anhydrous THF (2 mL) under argon was added pyr-
rolidine (250 mL) and Pd(dppf)Cl2·CH2Cl2 (20 mg, 0.03 mmol). The
reaction mixture was subsequently heated at 50 8C for 24 h. After
this time, solvent was removed under reduced pressure and the
residue was dissolved in CH2Cl2/water (20 mL, 1:1). The aqueous
layer was extracted with CH2Cl2 (3  10 mL) and the combined or-
ganic layers were dried over Na2SO4, filtered and concentrated to
dryness to yield a crude brown residue that was purified by re-
verse-phase HPLC (CH3CN/water) to afford a pale-yellow oil (42 mg,
41 %). 1H NMR (600 MHz, CDCl3): dH = 8.03 (1 H, d, J = 6.0 Hz), 7.49
(1 H, s), 7.18 (1 H, d, J = 8.0), 7.09 (1 H, s), 6.82 (1 H, d, J = 8.0 Hz),
4.80 (2 H, s), 4.14–4.06 (1 H, m), 3.87 (3 H, s), 3.92–3.82 (1 H, m), 3.16
(4 H, q, J = 7.0 Hz), 1.77 (3 H, d, J = 15.0 Hz), 1.26 (3 H, t, J = 7.0 Hz),
1.03 (6 H, t, J = 7.0 Hz); 13C NMR (151 MHz, CDCl3): dC = 160.8 (d, J =
20.0 Hz), 155.2, 153.2 (d, J = 160.0 Hz), 139.5, 133.3 (d, J = 11.0 Hz),
128.3 (d, J = 22.0 Hz), 127.2, 125.0, 124.1 (d, J = 3.0 Hz), 113.5, 111.5,
97.0, 84.9, 64.2, 61.3 (d, J = 6.0 Hz), 55.7, 46.0, 16.5 (d, J = 6.0 Hz),
13.6 (d, J = 105.0 Hz), 12.0; 31P{1H} NMR (243 MHz, CDCl3): dP =
39.44; UPLC (CH3CN/H2O, 0.1 % FA) tR = 1.22 min; (HRMS +) m/z
417.1954 [M+H]+ (C22H30N2O4P requires 417.1943).
(4-((3-(Diethylamino)-4-methoxyphenyl)ethynyl)-6-(ethoxy(me-
thyl)phosphoryl)pyridin-2-yl)methyl methanesulfonate, 17: The
alcohol 16 (22 mg, 0.05 mmol), methanesulfonic anhydride (22 mg,
0.11 mmol) and triethylamine (25 mL, 0.18 mmol) were combined
under argon in anhydrous THF (1.5 mL) under argon. The solution
was subsequently stirred at room temperature for 3 h. After this
time, solvent was removed under reduced pressure to yield a red
oil which was dissolved in CH2Cl2 (10 mL). The organic layer was
washed with water (3  10 mL), dried over Na2SO4 and evaporated
to dryness to afford the mesylate 17 (20 mg, 77 %). The compound
was used directly in the next step without further purification;
1H NMR (298 K, 400 MHz, CDCl3): dH = 8.07 (1 H, d, J = 6.0 Hz), 7.58–
7.54 (3 H, m), 6.89 (1 H, d, J = 7.0 Hz), 4.86 (2 H, s), 4.17–4.11 (1 H, m),
4.00–3.85 (3 H, m), 3.24 (4 H, br. s), 3.19 (3 H, s), 1.81 (3 H, d, J =
15.0 Hz), 1.30 (3 H, t, J = 7.0 Hz), 1.09 (6 H, t, J = 7.0 Hz), UPLC
(CH3CN/H2O, 0.1 % FA) tR = 1.39 min.
tert-Butyl 4,7-bis((6-(ethoxy(methyl)phosphoryl)pyridin-2-yl)-
methyl)-1,4,7-triazacyclonane-1-carboxylate, 20 : 1-tert-Butoxycar-
bonyl-1,4,7-triazacyclononane 19 (60 mg, 0.26 mmol) and freshly
prepared compound 18 (200 mg, 0.65 mmol) were dissolved in dry
CH3CN (5 mL) and K2CO3 (152 mg, 1.12 mmol) was added. The reac-
tion mixture was stirred at 60 8C for 12 h under argon at which
point the mixture was allowed to cool to room temperature. The
excess potassium salts were removed by filtration and the filtrate
was concentrated under reduced pressure. The residue was subse-
quently dissolved in CH2Cl2/water (40 mL, 1:1). The aqueous layer
was extracted with CH2Cl2 (3  20 mL) and the combined organic
layers were dried over Na2SO4, filtered and evaporated to dryness
to yield an orange oil. The residual oil was purified by reverse-
phase HPLC (CH3CN/water with 0.1 % formic acid) to yield com-
pound 20 (88 mg, 54 %) as an orange oil ; 1H NMR (298 K, 700 MHz,
CDCl3): dH = 7.91–7.86 (2 H, dd, J = 8.0 Hz, J = 6.0 Hz), 7.77–7.70 (2 H,
m), 7.61 (1 H, d, J = 8.0 Hz), 7.54 (1 H, d, J = 8.0 Hz), 4.09–4.02 (2 H,
m), 3.92 (4 H, s), 3.85–3.79 (2 H, m), 3.43–2.54 (12 H, m), 1.73 (3 H, d,
J = 15.0 Hz), 1.72 (3 H, d, J = 15.0 Hz), 1.43 (9 H, s), 1.22 (2  3 H, 2  t,
J = 7.0 Hz); 13C NMR (298 K, 100 MHz, CDCl3): dC = 165.0, 159.4 (d,
J = 20.0 Hz), 158.9 (d, J = 20.0 Hz), 155.4, 153.8 (d, J = 150.0 Hz),
136.7 (d, J = 9.0 Hz) 126.3 (d, J = 3.0 Hz), 126.1 (d, J = 3.0 Hz), 126.0,
80.0, 62.4, 61.0 (d, J = 4.0 Hz), 60.9 (d, J = 4.0 Hz), 55.1, 54.3, 53.9,
53.4, 49.6, 48.9, 28.5, 16.4 (d, J = 6.0 Hz), 13.4 (d, J = 100.0 Hz);
31P{1H} NMR (298 K, 162 MHz, CDCl3): dP = 40.18, 40.01; UPLC
(CH3CN/H2O, 0.1 % FA) tR = 1.47 min; (HRMS +) m/z 624.3088
[M+H]+ (C29H48N5O6P2 requires 624.3080).
Diethyl-(((1,4,7-triazacyclononane-1,4-diyl)bis(methylene))-
bis(pyridine-6,2-diyl))bis(methylphosphinate), 21: The mono-car-
bamate 20 (88 mg, 140 mmol) was dissolved in dry CH2Cl2 (3 mL)
before the addition of trifluoroacetic acid (0.6 mL). The solution
was stirred at room temperature for 30 min after which the solvent
was removed under reduced pressure. The residue was treated
with CH2Cl2 (2 mL) and the solvent removed under reduced pres-
sure again; this process was repeated several times. The crude mix-
ture was purified by reversed-phase HPLC (CH3CN/water with 0.1 %
formic acid) to afford a dark-brown oil (73.1 mg, quant.) ; 1H NMR
(298 K, 400 MHz, CDCl3): dH = 7.86–7.78 (4 H, m), 7.44 (2 H, d, J =
8.0 Hz), 4.19 (4 H, s), 4.16–4.08 (2 H, m), 3.94–3.88 (2 H, m), 3.40–
3.04 (12 H, m), 1.74 (6 H, d, J = 15.0 Hz), 1.28 (6 H, t, J = 7.0 Hz);
13C NMR (298 K, 100 MHz, CDCl3): dC = 158.0 (d, J = 20 Hz), 153.8 (d,
J = 150 Hz), 137.3 (d, J = 9.0 Hz) 126.0 (d, J = 20.0 Hz), 125.8 (d, J =
2.0 Hz), 61.6 (d, J = 6.0 Hz), 60.0, 51.5, 48.9, 44.5, 16.4 (d, J = 6.0 Hz),
13.7 (d, J = 100 Hz); 31P{1H} NMR (298 K, 162 MHz, CDCl3): dP =
40.12; UPLC (CH3CN/H2O, 0.1 % FA) tR = 1.09 min; (HRMS +) m/z




phosphinate), 22 : The disubstituted triazacyclononane 20 (8.5 mg,
16.2 mmol), mesylate 17 (16.0 mg, 32.4 mmol) and K2CO3 (5 mg,
35.4 mmol) were combined in anhydrous CH3CN (1.0 mL) and
stirred at 60 8C for 12 h under argon. After this time, the solvent
was removed under reduced pressure and the residue was dis-
solved in CH2Cl2/water (40 mL). The aqueous layer was extracted
with CH2Cl2 (3  20 mL). The combined organic layers were dried
over Na2SO4, filtered and concentrated to dryness. The crude prod-
uct was purified by reversed-phase HPLC (CH3CN/25 mm ammoni-
um bicarbonate buffer) to afford a yellow oil (7.4 mg, 50 %);
1H NMR (298 K, 400 MHz, CDCl3): dH = 8.04 (1 H, dd, J = 6.0 Hz, J =
2.0 Hz), 7.93 (2 H, app. t, J = 6.0 Hz), 7.83–7.78 (2 H, m), 7.69–7.65
(3 H, m), 7.21 (1 H, br. d, J = 8.0 Hz), 7.12 (1 H, d, J = 2.0 Hz), 6.87
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(1 H, d, J = 8.0 Hz), 4.18–3.76 (15 H, m), 3.20 (4 H, q, J = 7.0 Hz) 2.93–
2.89 (12 H, m), 1.79 (3 H, d, J = 15.0 Hz), 1.78 (6 H, d, J = 15.0 Hz),
1.29 (6 H, t, J = 7.0 Hz), 1.27 (3 H, t, J = 7.0 Hz), 1.07 (6 H, t, J =
7.0 Hz);13C NMR (101 MHz, CDCl3): dC = 161.5 (2  d, J = 12.0 Hz),
155.0, 153.6 (2  d, J = 160.0 Hz), 139.4, 136.4 (d, J = 9.0 Hz), 133.3
(d, J = 16.0 Hz), 127.8 (d, J = 20.0 Hz), 127.0, 126.4 (d, J = 4.0 Hz),
125.9, 125.6 (d, J = 20.0 Hz), 124.8, 113.4, 111.3, 96.4, 85.1, 64.4 (2 
s), 60.9 (2  d, J = 6.0 Hz), 55.6, 45.9, 16.5 (2  d, J = 6.0 Hz), 13.4 (2 
d, J = 105.0 Hz), 11.9; 31P{1H} NMR (298 K, 162 MHz, CDCl3): dP =
40.24 (2P), 39.99 (1P); UPLC (CH3CN/H2O, 0.1 % FA) tR = 1.35 min;
(HRMS +) m/z 922.4320 [M+H]+ (C46H67N7O7P3 requires 922.4315);
[EuL3]: The ligand 22 (2 mg, 2 mmol) was dissolved in a mixture of
CH3OH/H2O (1:1, 2 mL total) and the pH was adjusted to 12 using
aqueous NaOH solution (0.1 m). The solution was stirred at 60 8C
for 14 h. After cooling and adjustment to pH 7 using dilute hydro-
chloric acid (0.1 m), EuCl3·6 H2O (3 mg, 8 mmol) was added and the
reaction mixture was stirred at 60 8C for 15 h. The reaction mixture
was purified by reverse phase HPLC (CH3CN/water) to yield a white
powder after freeze drying (2 mg, 93 %); (HRMS +) m/z 986.2327
[M+H]+ (C40H52N7O7
151EuP3 requires 986.2340); UPLC (CH3CN/H2O,
0.1 % TFA) tR = 1.54 min; tH2O = (ms) = 0.50 (pH 9), 0.53 (pH 8), 0.74
(pH 7), 1.06 (pH 6), 1.15 (pH 5), 1.16 (pH 4); tMeOH = 0.89 ms; q = 0;
lexc = 331 nm; e331 nm = 12 000 m
1·cm1; FH2O = 0.01 % (pH 9), 6.3 %
(pH 4).
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